
    
      The study was an open label, randomised, two-treatment,two-period, two-sequence, single-dose,
      crossover,comparative bioequivalence study of Naproxen Sodium 550 mg tablets (containing
      naproxen 500 mg) manufactured by Dr. Reddy's Laboratories, ltd, Generics, India compared with
      ANAPROXÂ® DS 550 mg tablets (containing naproxen 500 mg) of Roche Pharmaceuticals, Roche
      Laboratories Inc. 340 Kingsland Street, New Jersey; in healthy,adult, human subjects under
      fed conditions with a wash out period of 10 days between two periods.
    
  